Farmakin: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
Farmakin
Largest movements
- Cash -€16,860
down €16,860 (-89.6%), from €18,809 to €1,949
mainly Contributions, distributions and other (-€25,000) and Net result for the year (-€3,596)
- Current investments -€10,000
no longer reported in 2025 (was €10,000)
- Receivables within one year -€6,552
down €6,552 (-59.1%), from €11,080 to €4,527
of which Trade receivables: -€4,721
- Tangible fixed assets +€2,610
up €2,610 (+101.3%), from €2,578 to €5,188
of which Other tangible fixed assets: +€3,321
- Deferred charges and accrued income +€967
up €967 (+73.1%), from €1,323 to €2,290
- Profit (loss) carried forward -€28,596
down €28,596 (-84.4%), from €33,899 to €5,303
- Tax, wage and social debts -€2,090
down €2,090 (-34.3%), from €6,089 to €3,999
- Gross operating margin -€16,774
down €16,774, from €16,345 to -€429
- Taxes -€3,091
down €3,091 (-95.8%), from €3,228 to €136
- Other operating charges +€714
up €714 (+225.2%), from €317 to €1,031
- Depreciation +€549
up €549 (+207.0%), from €265 to €814
- Financial income +€249
up €249 (+1566.0%), from €16 to €265
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €43,790 | €13,955 | -€29,835 | -68.1% |
| Fixed assets | 21/28 | €2,578 | €5,188 | +€2,610 | +101.3% |
| Tangible fixed assets | 22/27 | €2,578 | €5,188 | +€2,610 | +101.3% |
| Furniture and vehicles | 24 | €2,578 | €1,867 | -€711 | -27.6% |
| Other tangible fixed assets | 26 | - | €3,321 | +€3,321 | |
| Current assets | 29/58 | €41,212 | €8,766 | -€32,445 | -78.7% |
| Amounts receivable within one year | 40/41 | €11,080 | €4,527 | -€6,552 | -59.1% |
| Trade receivables | 40 | €6,209 | €1,488 | -€4,721 | -76.0% |
| Other amounts receivable | 41 | €4,870 | €3,039 | -€1,831 | -37.6% |
| Current investments | 50/53 | €10,000 | - | -€10,000 | |
| Cash at bank and in hand | 54/58 | €18,809 | €1,949 | -€16,860 | -89.6% |
| Deferred charges and accrued income | 490/1 | €1,323 | €2,290 | +€967 | +73.1% |
| Total equity and liabilities | 10/49 | €43,790 | €13,955 | -€29,835 | -68.1% |
| Equity | 10/15 | €34,019 | €5,423 | -€28,596 | -84.1% |
| Contributions | 10/11 | €120 | €120 | = | 0.0% |
| Profit (loss) carried forward | 14 | €33,899 | €5,303 | -€28,596 | -84.4% |
| Amounts payable | 17/49 | €9,771 | €8,532 | -€1,239 | -12.7% |
| Amounts payable within one year | 42/48 | €8,153 | €6,817 | -€1,336 | -16.4% |
| Trade debts | 44 | €574 | €986 | +€412 | +71.9% |
| Suppliers | 440/4 | €574 | €986 | +€412 | +71.9% |
| Taxes, remuneration and social security | 45 | €6,089 | €3,999 | -€2,090 | -34.3% |
| Taxes | 450/3 | €6,089 | €3,999 | -€2,090 | -34.3% |
| Other amounts payable | 47/48 | €1,491 | €1,832 | +€341 | +22.9% |
| Accrued charges and deferred income | 492/3 | €1,617 | €1,714 | +€97 | +6.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €265 | €814 | +€549 | +207.0% |
| Other operating charges | 640/8 | €317 | €1,031 | +€714 | +225.2% |
| Gross operating margin | 9900 | €16,345 | -€429 | -€16,774 | |
| Operating profit (loss) | 9901 | €15,763 | -€2,274 | -€18,037 | |
| Financial income | 75/76B | €16 | €265 | +€249 | +1566.0% |
| Recurring financial income | 75 | €16 | €265 | +€249 | +1566.0% |
| Financial charges | 65/66B | €1,685 | €1,451 | -€234 | -13.9% |
| Recurring financial charges | 65 | €1,685 | €1,451 | -€234 | -13.9% |
| Profit (loss) for the period before taxes | 9903 | €14,094 | -€3,460 | -€17,554 | |
| Income taxes | 67/77 | €3,228 | €136 | -€3,091 | -95.8% |
| Profit (loss) for the period | 9904 | €10,867 | -€3,596 | -€14,463 | |
| Profit (loss) for the period to be appropriated | 9905 | €10,867 | -€3,596 | -€14,463 |
Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.